173 related articles for article (PubMed ID: 38360138)
1. Colorectal cancer murine models: Initiation to metastasis.
Pothuraju R; Khan I; Jain M; Bouvet M; Malafa M; Roy HK; Kumar S; Batra SK
Cancer Lett; 2024 Apr; 587():216704. PubMed ID: 38360138
[TBL] [Abstract][Full Text] [Related]
2. Mouse models of colorectal cancer: Past, present and future perspectives.
Bürtin F; Mullins CS; Linnebacher M
World J Gastroenterol; 2020 Apr; 26(13):1394-1426. PubMed ID: 32308343
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer models for novel drug discovery.
Golovko D; Kedrin D; Yilmaz ÖH; Roper J
Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer.
Rizzo G; Bertotti A; Leto SM; Vetrano S
J Exp Clin Cancer Res; 2021 Jun; 40(1):178. PubMed ID: 34074330
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the development of transplanted colorectal cancer mouse models.
Yang YS; Liu CY; Wen D; Gao DZ; Lin S; He HF; Zhao XF
Transl Res; 2022 Nov; 249():128-143. PubMed ID: 35850446
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges.
Li J; Liu J; Xia W; Yang H; Sha W; Chen H
Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190
[TBL] [Abstract][Full Text] [Related]
7. Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challenges.
Durinikova E; Buzo K; Arena S
J Exp Clin Cancer Res; 2021 Jun; 40(1):185. PubMed ID: 34090508
[TBL] [Abstract][Full Text] [Related]
8. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived xenograft model in colorectal cancer basic and translational research.
Liu X; Xin Z; Wang K
Animal Model Exp Med; 2023 Feb; 6(1):26-40. PubMed ID: 36543756
[TBL] [Abstract][Full Text] [Related]
10. Engineered colorectal cancer tissue recapitulates key attributes of a patient-derived xenograft tumor line.
Hassani I; Anbiah B; Kuhlers P; Habbit NL; Ahmed B; Heslin MJ; Mobley JA; Greene MW; Lipke EA
Biofabrication; 2022 Jul; 14(4):. PubMed ID: 35617932
[TBL] [Abstract][Full Text] [Related]
11. Advanced Colorectal Cancer Orthotopic Patient-Derived Xenograft Models for Cancer and Stem Cell Research.
Chicote I; Cámara JA; Palmer HG
Methods Mol Biol; 2020; 2171():321-329. PubMed ID: 32705653
[TBL] [Abstract][Full Text] [Related]
12. Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development.
Roper J; Hung KE
Trends Pharmacol Sci; 2012 Aug; 33(8):449-55. PubMed ID: 22739258
[TBL] [Abstract][Full Text] [Related]
13. Experimental Murine Models for Colorectal Cancer Research.
Neto Í; Rocha J; Gaspar MM; Reis CP
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174036
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
[TBL] [Abstract][Full Text] [Related]
15. Orthotopic MC-38 Allograft as a Robust Preclinical Model of Colorectal Carcinoma.
Yakou MH; Afshar-Sterle S; Ernst M; Mielke LA
Methods Mol Biol; 2024; 2806():197-207. PubMed ID: 38676804
[TBL] [Abstract][Full Text] [Related]
16. Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis.
Moret R; Hellmers L; Zhang X; Gills J; Hite N; Klinger A; Maresh GA; Canter D; Bardot S; Margolin DA; Li L
J Vis Exp; 2019 May; (147):. PubMed ID: 31132059
[TBL] [Abstract][Full Text] [Related]
17. Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models.
Vangala D; Ladigan S; Liffers ST; Noseir S; Maghnouj A; Götze TM; Verdoodt B; Klein-Scory S; Godfrey L; Zowada MK; Huerta M; Edelstein DL; de Villarreal JM; Marqués M; Kumbrink J; Jung A; Schiergens T; Werner J; Heinemann V; Stintzing S; Lindoerfer D; Mansmann U; Pohl M; Teschendorf C; Bernhardt C; Wolters H; Stern J; Usta S; Viebahn R; Admard J; Casadei N; Fröhling S; Ball CR; Siveke JT; Glimm H; Tannapfel A; Schmiegel W; Hahn SA
Genome Med; 2021 Jul; 13(1):116. PubMed ID: 34271981
[TBL] [Abstract][Full Text] [Related]
18. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
Subtil B; Cambi A; Tauriello DVF; de Vries IJM
Front Immunol; 2021; 12():724883. PubMed ID: 34691029
[TBL] [Abstract][Full Text] [Related]
19. Organoid Models of Colorectal Pathology: Do They Hold the Key to Personalized Medicine? A Systematic Review.
DeHaan RK; Sarvestani SK; Huang EH
Dis Colon Rectum; 2020 Nov; 63(11):1559-1569. PubMed ID: 32868555
[TBL] [Abstract][Full Text] [Related]
20. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
